Harigai Masayoshi, Hara Masako, Kawamoto Manabu, Kawaguchi Yasushi, Sugiura Tomoko, Tanaka Michi, Nakagawa Miki, Ichida Hisae, Takagi Kae, Higami-Ohsako Satomi, Shimada Katsuhiko, Kamatani Naoyuki
Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
Arthritis Rheum. 2004 Jul;50(7):2167-77. doi: 10.1002/art.20340.
To determine the signal transduction pathways in CD14+ synovial cells from patients with rheumatoid arthritis (RA) after CD40 ligation, and to examine their role in amplifying synovial inflammation in affected joints.
Expression of messenger RNA was analyzed using quantitative reverse transcription-polymerase chain reaction. Cytokines and chemokines were measured using enzyme-linked immunosorbent assay. Activation of kinases was detected using Western blotting. Nuclear translocation of NF-kappaB was examined using immunohistochemistry. CD14+ synovial cells were enriched using magnetic cell sorting. Fibroblast-like synoviocytes (FLS) were obtained by passaging primary synovial cell culture.
Stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced expression of tumor necrosis factor alpha (TNFalpha), interleukin-1alpha (IL-1alpha), and IL-1beta. CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS compared with unstimulated CD14+ synovial cells, through TNFalpha-, IL-1alpha-, and IL-1beta-mediated pathways. Stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1/2, p38 MAPK, and NF-kappaB. Specific inhibitors of MAPK/ERK-1/2 kinases and p38 MAPK significantly reduced the production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells, and also inhibited production of these cytokines by freshly isolated synovial cells from RA patients.
These data indicate that the CD40-CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients to produce TNFalpha, IL-1alpha, and IL-1beta, which in turn amplifies inflammatory responses by stimulating FLS. Inhibition of the CD40-CD154 interaction or its signal transduction pathways would be a strong and efficient strategy for the management of synovial inflammation in RA.
确定类风湿关节炎(RA)患者CD14⁺滑膜细胞在CD40连接后的信号转导途径,并研究其在加剧受累关节滑膜炎症中的作用。
使用定量逆转录-聚合酶链反应分析信使核糖核酸的表达。使用酶联免疫吸附测定法测量细胞因子和趋化因子。使用蛋白质印迹法检测激酶的激活。使用免疫组织化学检查NF-κB的核转位。使用磁性细胞分选法富集CD14⁺滑膜细胞。通过传代原代滑膜细胞培养获得成纤维样滑膜细胞(FLS)。
重组可溶性CD154(rsCD154)刺激RA患者的CD14⁺滑膜细胞可显著诱导肿瘤坏死因子α(TNFα)、白细胞介素-1α(IL-1α)和IL-1β的表达。与未刺激的CD14⁺滑膜细胞相比,rsCD154加干扰素-γ(IFNγ)刺激的CD14⁺RA滑膜细胞通过TNFα、IL-1α和IL-1β介导的途径诱导FLS产生显著更高水平的IL-6、IL-8和单核细胞趋化蛋白1。rsCD154加IFNγ刺激可诱导ERK-1/2、p38丝裂原活化蛋白激酶(MAPK)和NF-κB的激活。MAPK/ERK-1/2激酶和p38 MAPK的特异性抑制剂可显著降低rsCD154加IFNγ刺激的CD14⁺滑膜细胞产生的TNFα和IL-1β,也可抑制RA患者新鲜分离的滑膜细胞产生这些细胞因子。
这些数据表明,CD40-CD154相互作用激活RA患者CD14⁺滑膜细胞中的ERK、p38和NF-κB途径,产生TNFα、IL-1α和IL-1β,进而通过刺激FLS放大炎症反应。抑制CD40-CD154相互作用或其信号转导途径将是治疗RA滑膜炎症的一种强有力且有效的策略。